COVID-19 highlights the acute need for non-invasive, point-of-care, remote monitoring

hemodynamic measurement solutions. Find out how CPS meets the need.

Sensydia in the news

March 29, 2025

Clinical data at ACC 2025 shows CPS provides accurate Non-Invasive assessment

Sensydia announced today that University of Minnesota investigators presented positive clinical findings from a recent study evaluating the company’s AI-powered, non-invasive Cardiac Performance System (CPS™) in a poster presentation at the American College of Cardiology (ACC) 2025 Annual Scientific Session & Expo at the McCormick Place Convention Center in Chicago, IL.

Learn More

Sensydia in the news

Clinical data at ACC 2025 shows CPS provides accurate Non-Invasive assessment

Clinical data presented at ACC 2025 shows Sensydia CPS™ provides accurate assessment of mean pulmonary artery pressure non-invasively

Sensydia Completes Fifth Study for Heart-Sound AI

Sensydia secures $3M NIH grant to advance AI-based cardiac assessment platform

Sensydia raises $8M round to advance breakthrough CPS cardiac assessment platform

Sensydia Achieves Study Target for Heart-Sound AI

Sensydia Receives FDA Breakthrough Device Designation for CPS Non-Invasive Cardiac Monitoring Device